Insider · CIK 0001597334
Frank Pasqualone
Files at ENVB (Enveric Biosciences, Inc.). First filing -, latest -.
In brief
Frank Pasqualone files SEC Form 4 as director at ENVB (Enveric Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Frank Pasqualone has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +18,518 | $0.00 | $0 | 26,423 | Jun 3, 2026 |
| Dec 23, 2025 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +7,633 | $0.00 | $0 | 7,904 | Dec 30, 2025 |
| Oct 9, 2024 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +47,733 | $0.00 | $0 | 48,733 | Oct 11, 2024 |
Questions about Frank Pasqualone
Answered from the filings on this page, as of the latest one.
Is Frank Pasqualone buying or selling?
Frank Pasqualone has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Frank Pasqualone's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frank Pasqualone has 0.
Where does Frank Pasqualone file Form 4?
Frank Pasqualone has filed Form 4 at ENVB (Enveric Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.